Orphan designation: 2-[[(4-Methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazol-5-ol Treatment of multiple system atrophy, 09/01/2026 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 10 April 2026 - 15:21

Orphan designation: 2-[[(4-Methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazol-5-ol Treatment of multiple system atrophy, 09/01/2026 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-25-3187

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters